2015
DOI: 10.1038/ncomms7374
|View full text |Cite
|
Sign up to set email alerts
|

IL-10 inhibits neuraminidase-activated TGF-β and facilitates Th1 phenotype during early phase of infection

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
48
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 28 publications
(50 citation statements)
references
References 49 publications
2
48
0
Order By: Relevance
“…With the adoptive transfer of HA antigen-specific CD4+ and CD8+ T cells, experiments in our transgenic mouse model revealed that antigen-specific T cell response elevates the level of protection with sterilization effect from the level with accelerated virus clearance only. Although the physiological significance is a concern with unusually high precursor frequency of T cells of certain antigen specificity in adoptive transfer approach, we and others have demonstrated that the frequency of specific T cells with adoptive transfer is not appreciably different from those with physiological T cell expansion2425515253. We also have identified LAG-3 as the target for cancer immunotherapy with this approach and anti-LAG-3 has been in phase I clinical trial since 2013 (ref.…”
Section: Discussionmentioning
confidence: 86%
See 4 more Smart Citations
“…With the adoptive transfer of HA antigen-specific CD4+ and CD8+ T cells, experiments in our transgenic mouse model revealed that antigen-specific T cell response elevates the level of protection with sterilization effect from the level with accelerated virus clearance only. Although the physiological significance is a concern with unusually high precursor frequency of T cells of certain antigen specificity in adoptive transfer approach, we and others have demonstrated that the frequency of specific T cells with adoptive transfer is not appreciably different from those with physiological T cell expansion2425515253. We also have identified LAG-3 as the target for cancer immunotherapy with this approach and anti-LAG-3 has been in phase I clinical trial since 2013 (ref.…”
Section: Discussionmentioning
confidence: 86%
“…As there should be virus antigen shedding with the second possibility, we tested virus antigen shedding by the viruses of lethal challenge in pre-infected mice through antigen-driven activation of influenza hemagglutinin (HA) antigen-specific 6.5 CD4+ T cells. At first, naïve HA-specific 6.5 CD4+ T cells were adoptively transferred on the same day with first virus exposure2425. Virus antigens of the first intranasal inoculation (pre-infection) activated adoptively transferred naïve HA-specific 6.5 CD4+ T cells on day 7 after pre-infection (Before, Fig.…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations